The use of surface plasmon resonance spectroscopy in characterizing small molecule-based nerve growth factor inhibitors
Year: 2016
Type: dissertation
Abstract: Neurotrophins are well known for their effects on neuronal survival and growth. Over the \npast two decades, considerable evidence has accumulated from both human and animal \nmodels that one neurotrophin, nerve growth factor (NGF), is a peripheral pain mediator, \nparticularly in inflammatory pain states. NGF is upregulated in a wide variety of \ninflammatory conditions, and NGF-neutralizing molecules are effective analgesic agents in \nmany models of persistent pain. Such molecules are now being evaluated in clinical trials \nand although seemingly effective in early clinical studies, many deteriorating side effects are \nnow being brought to light. Thus, a need still remains for novel NGF-quenching therapeutics. \nIn the past two decades, a handful of small molecule NGF-inhibitors have been described, \nhowever, their effects are still quite minimal compared to other inhibitory agents. The \ncentral aim of this thesis was to use novel screening strategies to identify small molecule \nNGF-inhibitors capable of modulating NGF signalling with greater efficiency than previously \nreported compounds for the purpose of therapeutic development. Using surface plasmon resonance (SPR) spectroscopy, established NGF-inhibitors and a series of novel compounds \nwere analyzed for their specificity to NGF and their inhibitory properties of NGF binding to \nthe TrkA receptor. In vitro techniques confirmed the high nanomolar inhibitory properties of \na novel compound, BVNP-0197. Molecular modeling techniques also described a putative \nbinding domain for BVNP-0197 to NGF at the loop II/IV cleft, an alternative domain than \npreviously described by small molecule compounds. This binding domain describes an area with higher specificity for TrkA over binding for p75NTR. Serum albumin was also described as \nhaving a role in the binding events that occur between small molecule compounds to NGF in \nvitro. SPR kinetic analysis established that the addition of serum albumin into solution with \nsmall molecule compounds increased their specificity for NGF, as well as decreased their \npotential toxicity. The findings presented in this thesis will contribute to the future \ndevelopment of small molecule NGF-inhibitors.
Author: Allison E. Kennedy
Institution: Laurentian University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2586795268
